Clinical evaluation working guide
Demonstrating Equivalence Under MDR: MDCG 2020-5 Checklist
Demonstrating equivalence under MDR requires a documented argument supported by adequate data. Similar technology, a shared indication or a familiar predicate comparison is not, by itself, an MDR equivalence demonstration.
This guide helps a manufacturer prepare an evidence-access and comparison record before relying on another device’s clinical data. It does not decide equivalence for a particular device or replace a device-specific assessment.
Define the claim that depends on equivalence
First identify which clinical conclusion would rely on the other device’s data. If the studies are being used only to describe the treatment landscape or state of the art, label that role explicitly. Do not treat background evidence as equivalent-device evidence without the required justification.
MDCG 2020-5 explains equivalence in the context of the MDR and distinguishes it from the use of similar-device data. The practical output should be a reasoned comparison, not a table where every difference is marked “not relevant” without supporting information.
Build three linked comparisons
Technical: identify the relevant design, operating characteristics and performance features, and record differences with evidence references. Biological: assess the applicable materials, tissue contact and related characteristics. Clinical: compare the intended clinical use, population, users and relevant performance.
These dimensions work together. An apparently close clinical indication does not cancel an unexplained technical or biological difference. Record who assessed each difference, which source supports the conclusion, and what uncertainty remains. Where a comparison is not applicable, explain the reason rather than leaving a blank cell.
Check access before committing to the strategy
For each comparison field, record the document available, version, owner and access limitation. Public product brochures may omit information needed to assess a difference. A published outcome paper may not identify the configuration tested. Resolve these limitations before building the CER around an assumption of equivalence.
Class III and implantable-device investigation exceptions have specific conditions under Article 61. Where the relevant route involves another manufacturer, review the applicable access and contractual requirements with your regulatory team. A writing provider should not promise that public literature alone will satisfy every equivalence route.
Use a difference-to-conclusion log
A useful working log has columns for the characteristic, subject-device evidence, comparator evidence, observed difference, potential clinical effect, rationale, source and unresolved action. Keep the appraisal separate from the final narrative so reviewers can follow how the conclusion was reached.
For an illustrative example, identical intended use does not settle whether a changed energy-delivery characteristic affects tissue response. That question needs appropriate technical and clinical reasoning. This example is a review prompt, not a claim that either device is equivalent or that a particular study design would establish equivalence.
What to do when equivalence is not established
Keep similar-device literature in its appropriate contextual role, identify the missing support, and reassess the device’s own clinical evidence. The next step might be additional analysis, a change to the clinical argument or further evidence generation; it is not automatically a stronger equivalence statement.
If a notified body has questioned the comparison, map each concern to the source record and revised reasoning. For a report outline that keeps these distinctions visible, see the CER template and planning worksheet. For directive-era evidence, see legacy device clinical evaluation support.
Common questions
Are similar devices and equivalent devices interchangeable?
No. Similar-device data can inform clinical context. Using another device’s clinical data through an equivalence argument requires a separate, supported demonstration.
Can equivalence be based only on a published study?
A study may contribute, but it may not provide the technical, biological, clinical and access information needed for the applicable assessment. Evaluate the evidence available for each relevant comparison.
Does this checklist establish equivalence?
No. It organizes questions and records. A device-specific assessment must reach and justify the conclusion using appropriate evidence and the applicable requirements.
Primary regulatory sources
- MDCG 2020-5: clinical evaluation equivalence
- Regulation (EU) 2017/745: Article 61, Annex XIV and Article 120
Check the applicable consolidated legislation and current guidance for the device. Guidance supports interpretation; it does not replace the MDR or a device-specific assessment.
Connected services and working guides
For the complete evaluation package, see IMTS Clinical Evaluation Report writing services.
- CER Remediation and Notified Body Response Support
- Legacy Device CERs for the MDD-to-MDR Transition
- MEDDEV 2.7/1 Rev 4 vs MDR: What Changes for a CER?
If equivalence questions are holding up a review, discuss CER remediation and notified body response support. For the full evaluation, see IMTS CER writing services.
Book a Scoping Call